Teemu Viinikangas, Elham Khosrowabadi, Sakari Kellokumpu
{"title":"N-Glycan Biosynthesis: Basic Principles and Factors Affecting Its Outcome.","authors":"Teemu Viinikangas, Elham Khosrowabadi, Sakari Kellokumpu","doi":"10.1007/978-3-030-76912-3_7","DOIUrl":null,"url":null,"abstract":"<p><p>Carbohydrate chains are the most abundant and diverse of nature's biopolymers and represent one of the four fundamental macromolecular building blocks of life together with proteins, nucleic acids, and lipids. Indicative of their essential roles in cells and in multicellular organisms, genes encoding proteins associated with glycosylation account for approximately 2% of the human genome. It has been estimated that 50-80% of all human proteins carry carbohydrate chains-glycans-as part of their structure. Despite cells utilize only nine different monosaccharides for making their glycans, their order and conformational variation in glycan chains together with chain branching differences and frequent post-synthetic modifications can give rise to an enormous repertoire of different glycan structures of which few thousand is estimated to carry important structural or functional information for a cell. Thus, glycans are immensely versatile encoders of multicellular life. Yet, glycans do not represent a random collection of unpredictable structures but rather, a collection of predetermined but still dynamic entities that are present at defined quantities in each glycosylation site of a given protein in a cell, tissue, or organism.In this chapter, we will give an overview of what is currently known about N-glycan synthesis in higher eukaryotes, focusing not only on the processes themselves but also on factors that will affect or can affect the final outcome-the dynamicity and heterogeneity of the N-glycome. We hope that this review will help understand the molecular details underneath this diversity, and in addition, be helpful for those who plan to produce optimally glycosylated antibody-based therapeutics.</p>","PeriodicalId":36906,"journal":{"name":"Experientia supplementum (2012)","volume":"112 ","pages":"237-257"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experientia supplementum (2012)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-030-76912-3_7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 7
Abstract
Carbohydrate chains are the most abundant and diverse of nature's biopolymers and represent one of the four fundamental macromolecular building blocks of life together with proteins, nucleic acids, and lipids. Indicative of their essential roles in cells and in multicellular organisms, genes encoding proteins associated with glycosylation account for approximately 2% of the human genome. It has been estimated that 50-80% of all human proteins carry carbohydrate chains-glycans-as part of their structure. Despite cells utilize only nine different monosaccharides for making their glycans, their order and conformational variation in glycan chains together with chain branching differences and frequent post-synthetic modifications can give rise to an enormous repertoire of different glycan structures of which few thousand is estimated to carry important structural or functional information for a cell. Thus, glycans are immensely versatile encoders of multicellular life. Yet, glycans do not represent a random collection of unpredictable structures but rather, a collection of predetermined but still dynamic entities that are present at defined quantities in each glycosylation site of a given protein in a cell, tissue, or organism.In this chapter, we will give an overview of what is currently known about N-glycan synthesis in higher eukaryotes, focusing not only on the processes themselves but also on factors that will affect or can affect the final outcome-the dynamicity and heterogeneity of the N-glycome. We hope that this review will help understand the molecular details underneath this diversity, and in addition, be helpful for those who plan to produce optimally glycosylated antibody-based therapeutics.
碳水化合物链是自然界中最丰富、最多样的生物聚合物,与蛋白质、核酸和脂质一起,是构成生命的四大基本大分子之一。编码与糖基化相关的蛋白质的基因约占人类基因组的2%,这表明了它们在细胞和多细胞生物中的重要作用。据估计,50% -80%的人类蛋白质都携带碳水化合物链——聚糖——作为其结构的一部分。尽管细胞只使用9种不同的单糖来制造聚糖,但它们在聚糖链上的顺序和构象变化,以及链分支的差异和频繁的合成后修饰,可以产生大量不同的聚糖结构,其中数千种被估计为细胞携带重要的结构或功能信息。因此,聚糖是多细胞生命的极其通用的编码器。然而,聚糖并不代表不可预测结构的随机集合,而是一种预先确定但仍然动态的实体集合,它们以确定的数量存在于细胞、组织或生物体中给定蛋白质的每个糖基化位点。在本章中,我们将概述目前已知的高等真核生物中n -聚糖的合成,不仅关注过程本身,还关注将影响或可能影响最终结果的因素- n -聚糖的动态性和异质性。我们希望这篇综述将有助于理解这种多样性背后的分子细节,此外,对那些计划生产最佳糖基化抗体治疗方法的人有帮助。